Graham Jackson Consultant Haematologist Newcastle

Graham Jackson Consultant Haematologist Newcastle

Graham Jackson Consultant Haematologist Newcastle leads in the field of haematological malignancies. He treats myeloma, lymphoma, acute leukaemias, and performs stem cell transplantation and intra-thecal chemotherapy. He provides expert care at Newcastle Hospitals NHS Foundation Trust and teaches as a Professor of Clinical Haematology at Newcastle University. His work combines clinical excellence with ongoing research and education, making him a trusted leader in haematology.

Clinical Experience and Background

Professor Graham Jackson has a distinguished medical career. He graduated from Cambridge in 1980, followed by medical studies at Westminster School of Medicine. In 1986, he earned his MRCP and soon moved to Newcastle University to pursue an MD, which he completed in 1992. His commitment to haematology deepened with the MRCPath in 1993, FRCP in 1999, and FRCPath in 2000.

Throughout his career, he gained international experience, including work at the renowned Fred Hutchinson Cancer Centre in Seattle. His clinical practice focuses on bone marrow transplantation and advanced therapies for blood cancers, offering patients both cutting-edge treatments and compassionate care.

Research and Academic Contributions

Graham Jackson Consultant Haematologist Newcastle also excels in research. His studies focus on drug resistance in myeloma, long-term bone marrow transplant follow-up, and the cytokine profile of acute and chronic GVHD. He actively contributes to national and international research initiatives, ensuring patients benefit from the latest findings in blood cancer treatments.

He has published more than 125 peer-reviewed papers and authored several book chapters. Additionally, he has contributed to key clinical guidelines, including the BCSH anti-fungal guidelines, and is actively involved in national myeloma clinical trials.

Leadership in Haematology

Professor Jackson’s leadership extends beyond clinical and research roles. He served as President of the British Society of Haematology in 2014 and previously held the position of treasurer. He also presides over the British Society of Blood and Marrow Transplantation (BSBMT). His expertise is recognized through appointments to the Clinical Trials Awards and Advisory Committee (CTAAC) and the Leukaemia and Lymphoma Research grants committee. His active participation in these organizations helps shape the future of haematology care in the UK and internationally.